At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
KVUE Kenvue Inc
Pre-Market Trading 11-22 06:54:53 EST
24.09
+0.31
+1.30%
盘前23.51
-0.58-2.41%
04:12 EST
High24.24
Low23.69
Vol8.33M
Open23.79
D1 Closing23.78
Amplitude2.31%
Mkt Cap46.19B
Tradable Cap46.13B
Total Shares1.92B
T/O200.76M
T/O Rate0.44%
Tradable Shares1.91B
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
BNP Paribas Exane Lifts Price Target on Kenvue to $24 From $22
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.